Skip to main content

Table 4 Comparison of polysomnographic data between patients with and without insomnia

From: Insomnia in adults with cystic fibrosis: strong association with anxiety/depression and impaired quality of life

 

Patients with insomnia (ISI score > 7) (n = 8)

Patients without insomnia (ISI score ≤ 7) (n = 6)

P

Sleep Latency (min)

26 (16–29)

19 (11–25)

0.57

Sleep latency > 45 min

1 (13%)

1 (17%)

1.00

Total Sleep Time (min)

415 (343–500)

453 (441–526)

0.35

 N1 (min)

16 (8–21)

10 (8–15)

0.57

 N1 (% TST)

4 (2–5)

2 (2–3)

0.32

 N2 (min)

242 (182–274)

195 (183–234)

0.57

 N2 (% TST)

51 (44–57)

45 (40–52)

0.29

 N3 (min)

80 (72–118)

124 (95–145)

0.16

 N3 (% TST)

21 (15–26)

26 (21–32)

0.42

 REM (min)

87 (65–112)

119 (112–164)

0.13

 REM (% TST)

22 (18–23)

27 (25–30)

0.05

Sleep Efficiency (%)

88 (86–92)

94 (88–96)

0.18

Arousal index (/h)

11 (6–14)

8 (5–12)

0.35

Wake after sleep onset (min)

60 (35–109)

37 (28–81)

0.66

PLM (/h)

0 (0–0)

0 (0–0)

1.00

PLM > 15/h

0 (0%)

0 (0%)

1.00

Apnea–Hypopnea Index (/h)

0 (0–2)

1 (0–4)

0.85

Mean SpO2 during sleep (%)

92 (92–94)

96 (94–96)

 < 0.05

% SpO2 < 90% asleep

0 (0–3)

0 (0–0)

0.53

Oxygen Desaturation Index (3%) (/h)

3 (2–7)

4 (3–6)

0.45

Mean PtcCO2 during sleep (mmHg)

45 (41–46)

46 (43–47)

0.25

Max PtcCO2 during sleep (mmHg)

47 (44–50)

50 (47–51)

0.59

% PtcCO2 > 50 mmHg

0 (0–2)

0 (0–2)

1.00

  1. Data are expressed as median (interquartile range) and as number (percentage) of patients
  2. REM: rapid eye movement sleep, PLM: periodic leg movements, SpO2: pulse oxygen saturation, PtcCO2: transcutaneous carbon dioxide pressure